What is carcinoembryonic antigen (CEA) a marker for?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

CEA is Primarily a Marker for Colorectal Cancer

CEA (carcinoembryonic antigen) is primarily a tumor marker for colorectal cancer, used for staging, postoperative surveillance, and monitoring treatment response—not for screening or diagnosis. 1

Primary Clinical Applications in Colorectal Cancer

Based on ASCO guidelines, CEA serves four distinct roles in colorectal cancer management 1:

1. Preoperative Staging

  • CEA may be ordered before surgery to assist in staging and surgical planning
  • Elevated preoperative CEA (≥5 mg/mL) correlates with poorer prognosis
  • Provides baseline for postoperative surveillance utility
  • Also indicated before resection of liver metastases, where it predicts prognosis 1

2. Postoperative Surveillance

Measure CEA every 3 months for at least 3 years after diagnosis in stage II or III disease, but only if the patient is a surgical or systemic therapy candidate. 1

  • An elevated CEA (confirmed by retesting) warrants further metastatic workup
  • Wait until chemotherapy completion before initiating surveillance, as chemotherapy can falsely elevate CEA 1
  • The rationale: early detection of recurrence allows intervention when systemic therapy can improve survival 1

3. Monitoring Metastatic Disease

CEA is the marker of choice for monitoring metastatic colorectal cancer during systemic therapy. 1

  • Measure at treatment start and every 1-3 months during active treatment
  • Persistently rising values suggest progressive disease even without radiographic confirmation
  • Critical caveat: Spurious early rises can occur in the first 4-6 weeks of new therapy, especially with oxaliplatin—interpret cautiously 1

4. What CEA Should NOT Be Used For

  • Not for screening: Sensitivity is too low despite high specificity 1
  • Not for diagnosis: Cannot independently establish cancer diagnosis 2
  • Not for determining adjuvant therapy: Insufficient data to guide treatment decisions based on CEA alone 1
  • Not as sole justification for systemic therapy: Elevated CEA alone doesn't warrant treatment without confirmatory imaging 1

Beyond Colorectal Cancer

While CEA is most established for colorectal cancer, it can be elevated in other conditions 3:

Other Malignancies with CEA Elevation:

  • Medullary thyroid cancer (MTC): CEA is produced by neoplastic C cells alongside calcitonin; >50% of MTC patients have elevated CEA, and it correlates with aggressive disease 4, 5
  • Pancreatic cancer: One of only two localized tumors (with colorectal) that produces CEA elevation above benign disease levels 6
  • Lung cancer: Elevated CEA correlates with metastatic disease burden and multiple metastases 7
  • Other cancers: breast, gastric, ovarian, but marked elevation typically indicates distant metastasis 6

Non-Malignant Causes:

CEA can be elevated in benign conditions including gastritis, peptic ulcer disease, diverticulitis, liver disease, COPD, diabetes, and any acute/chronic inflammatory state 1. Healthy individuals >65 years also have higher baseline CEA levels 3.

Key Clinical Pitfalls

  1. False elevations during chemotherapy: Wait 4-6 weeks after starting new therapy before interpreting rising CEA as progression 1
  2. Benign causes: Always consider non-malignant etiologies, particularly inflammatory and liver conditions 1
  3. Laboratory variability: CEA levels may differ between laboratories—use consistent testing sites 1
  4. Age-related elevation: Elderly patients naturally have higher baseline CEA 3
  5. When GI workup is negative: Consider medullary thyroid cancer, especially if CEA is markedly elevated (check serum calcitonin) 4

Practical Algorithm

For an elevated CEA:

  1. If known colorectal cancer: Use per surveillance/monitoring guidelines above
  2. If no known cancer:
    • Evaluate for colorectal cancer first (colonoscopy)
    • If GI workup negative and CEA markedly elevated: check thyroid (calcitonin, thyroid imaging for MTC) 4
    • Consider other malignancies based on clinical context
    • Rule out benign causes (inflammatory, liver, pulmonary conditions) 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.